Fenchem Biotek Ltd.
FDA import alert and refusal historyNanjing, ChinaFEI 3013257323
As of October 25, 2026, Fenchem Biotek Ltd. (Nanjing, China) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for ginseng extract, published by FDA on September 16, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-08 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Fenchem Biotek Ltd.
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 99-08red listGinseng extractSource
Questions about Fenchem Biotek Ltd.
- Is Fenchem Biotek Ltd. on an FDA import alert?
- Yes. As of October 25, 2026, Fenchem Biotek Ltd. is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for ginseng extract; FDA published the listing on September 16, 2009.
- Has FDA refused shipments from Fenchem Biotek Ltd.?
- No FDA import refusals for Fenchem Biotek Ltd. appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Fenchem Biotek Ltd.'s FEI number?
- Fenchem Biotek Ltd.'s FDA Establishment Identifier (FEI) is 3013257323.
- Can shipments from Fenchem Biotek Ltd. still enter the U.S.?
- Shipments of ginseng extract from Fenchem Biotek Ltd. can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Fenchem Biotek Ltd.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.